IQVIA Holdings EBITDA 2011-2025 | IQV
IQVIA Holdings annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- IQVIA Holdings EBITDA for the quarter ending March 31, 2025 was $766M, a 1.16% decline year-over-year.
- IQVIA Holdings EBITDA for the twelve months ending March 31, 2025 was $3.328B, a 5.08% increase year-over-year.
- IQVIA Holdings 2024 annual EBITDA was $3.337B, a 6.96% increase from 2023.
- IQVIA Holdings 2023 annual EBITDA was $3.12B, a 5.98% increase from 2022.
- IQVIA Holdings 2022 annual EBITDA was $2.944B, a 10.1% increase from 2021.
| IQVIA Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $3,337 |
| 2023 | $3,120 |
| 2022 | $2,944 |
| 2021 | $2,674 |
| 2020 | $2,036 |
| 2019 | $1,992 |
| 2018 | $1,893 |
| 2017 | $1,728 |
| 2016 | $926 |
| 2015 | $793 |
| 2014 | $718 |
| 2013 | $592 |
| 2012 | $504 |
| 2011 | $467 |
| 2010 | $498 |
| IQVIA Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $766 |
| 2024-12-31 | $934 |
| 2024-09-30 | $833 |
| 2024-06-30 | $795 |
| 2024-03-31 | $775 |
| 2023-12-31 | $822 |
| 2023-09-30 | $783 |
| 2023-06-30 | $787 |
| 2023-03-31 | $728 |
| 2022-12-31 | $740 |
| 2022-09-30 | $724 |
| 2022-06-30 | $726 |
| 2022-03-31 | $754 |
| 2021-12-31 | $728 |
| 2021-09-30 | $642 |
| 2021-06-30 | $634 |
| 2021-03-31 | $670 |
| 2020-12-31 | $638 |
| 2020-09-30 | $511 |
| 2020-06-30 | $375 |
| 2020-03-31 | $512 |
| 2019-12-31 | $483 |
| 2019-09-30 | $507 |
| 2019-06-30 | $494 |
| 2019-03-31 | $508 |
| 2018-12-31 | $504 |
| 2018-09-30 | $467 |
| 2018-06-30 | $454 |
| 2018-03-31 | $468 |
| 2017-12-31 | $423 |
| 2017-09-30 | $453 |
| 2017-06-30 | $413 |
| 2017-03-31 | $439 |
| 2016-12-31 | $295 |
| 2016-09-30 | $232 |
| 2016-06-30 | $183 |
| 2016-03-31 | $216 |
| 2015-12-31 | $219 |
| 2015-09-30 | $205 |
| 2015-06-30 | $194 |
| 2015-03-31 | $175 |
| 2014-12-31 | $193 |
| 2014-09-30 | $181 |
| 2014-06-30 | $172 |
| 2014-03-31 | $172 |
| 2013-12-31 | $162 |
| 2013-09-30 | $154 |
| 2013-06-30 | $132 |
| 2013-03-31 | $143 |
| 2012-12-31 | $124 |
| 2012-09-30 | $137 |
| 2012-06-30 | $127 |
| 2012-03-31 | $117 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.640B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.818B | 83.14 |
| Thermo Fisher Scientific (TMO) | United States | $156.486B | 18.93 |
| Edwards Lifesciences (EW) | United States | $44.464B | 29.15 |
| Alcon (ALC) | Switzerland | $43.874B | 29.65 |
| IDEXX Laboratories (IDXX) | United States | $42.296B | 48.61 |
| DexCom (DXCM) | United States | $33.259B | 51.41 |
| Mettler-Toledo (MTD) | United States | $25.284B | 30.07 |
| STERIS (STE) | Ireland | $23.842B | 26.26 |
| Waters (WAT) | United States | $20.819B | 29.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.720B | 0.00 |
| Hologic (HOLX) | United States | $14.516B | 15.77 |
| Sysmex ADR (SSMXY) | Japan | $10.481B | 29.73 |
| Penumbra (PEN) | United States | $9.903B | 77.73 |
| Masimo (MASI) | United States | $9.110B | 33.61 |
| Globus Medical (GMED) | United States | $8.322B | 19.83 |
| Teleflex (TFX) | United States | $5.543B | 9.15 |
| Glaukos (GKOS) | United States | $5.465B | 0.00 |
| TransMedics (TMDX) | United States | $4.764B | 103.57 |
| Integer Holdings (ITGR) | United States | $4.275B | 22.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.554B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.595B | 15.45 |
| Veracyte (VCYT) | United States | $2.183B | 30.64 |
| Nihon Kohden (NHNKY) | Japan | $2.111B | 24.21 |
| Elekta AB (EKTAY) | Sweden | $1.910B | 17.17 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.495B | 0.00 |
| Artivion (AORT) | United States | $1.249B | 116.96 |
| Pulse Biosciences (PLSE) | United States | $1.167B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.086B | 5.78 |
| Beta Bionics (BBNX) | United States | $0.835B | 0.00 |
| SiBone (SIBN) | United States | $0.814B | 0.00 |
| IRadimed (IRMD) | United States | $0.762B | 38.67 |
| RxSight (RXST) | United States | $0.638B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.597B | 9.29 |
| Mesa Laboratories (MLAB) | United States | $0.569B | 13.34 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| AxoGen (AXGN) | United States | $0.486B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.453B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.351B | 9.35 |
| Pacific Biosciences Of California (PACB) | United States | $0.348B | 0.00 |
| 908 Devices (MASS) | United States | $0.255B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.241B | 14.58 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.193B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.182B | 0.00 |
| Inogen (INGN) | United States | $0.178B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.170B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Accuray (ARAY) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 51.30 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.37 |